UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One):

x  Form 10-K

o  Form 20-F

o  Form 11-K

 

o  Form 10-Q

o  Form 10-D

o  Form N-SAR

 

For Period Ended: December 31, 2009

 

o  Transition Report on Form 10-K

o  Transition Report on Form 10-Q

o  Transition Report on Form 20-F

o  Transition Report on Form N-SAR

o  Transition Report on Form 11-K

 

 

For the Transition Period Ended :________________________

 

Read attached instruction sheet before preparing form. Please print or type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification related to a portion of the filing checked above, identify the Item(s) to which the notification relates:

__________________________________________________________________

PART I - REGISTRANT INFORMATION

 

Full name of registrant:    Manhattan Scientifics, Inc.                                                                      

Former name if applicable:                                                                                                              

Address of principal executive office (street and number): 405 Lexington Avenue, 32nd Floor   

 

City, state and zip code:    New York, New York, 10174                                                                 

 

 

                                                                                           

 

PART II - RULE 12b-25 (b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

 

 

(a)       The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense.

 

 

x

 

(b)       The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or Form N-CSR. or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

 

(c)       The accountant’s statement or other exhibit required by Rule 12b-25(c )has been attached if applicable.

 

PART III – NARRATIVE

 

State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR or Form N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

The Company’s Annual Report on Form 10-K for the year ended December 31, 2009 cannot be filed within the prescribed time period because the Company requires additional time for compilation and review to insure adequate disclosure of certain information required to be included in the Form 10-K. The Company plans to file its Annual Report on Form 10-K on or before the 15 th calendar day following the prescribed due date.

 

PART IV - OTHER INFORMATION

 

(1)

Name and telephone number of person to contact in regard to this notification:

 

 

Emmanuel Tsoupanarias, Chief Executive Officer

(212) 551-0577

 

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s)

 

 

x Yes

o No

 

 

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 

o Yes

x No

 

 

                Manhattan Scientifics, Inc.                
(Name of Registrant as specified in Charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date: March 31, 2010

By: /s/ Emmanuel Tsoupanarias          

Emmanuel Tsoupanarias

Chief Executive Officer

 

Manhattan Scientifics (PK) (USOTC:MHTX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Manhattan Scientifics (PK).
Manhattan Scientifics (PK) (USOTC:MHTX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Manhattan Scientifics (PK).